Topics in Companion Animal Medicine
Volume 24, Issue 2 , Pages 71-99 , May 2009

Pharmacologic Advances in Canine and Feline Reproduction

  • Valerie J. Wiebe, PharmD, FSVHP, Dipl ICVP

      Affiliations

    • Department of Pharmacy, Veterinary Medical Teaching Hospital, and Department of Medicine and Epidemiology, University of California, Davis, CA, USA
    • Corresponding Author InformationAddress reprint requests to: Valerie Wiebe, PharmD, Pharmacy, Veterinary Teaching Hospital, 1 Shields Rd, University of California, Davis, CA 95616
    • ,
  • James P. Howard, DVM

      Affiliations

    • Animal Medical Center of Jefferson City, MO, USA

References 

  1. Kutzler MA. Estrus induction and synchronization in canids and felids. Theriogenology. 2007;68(3):354–374
  2. Cirit O, Bachinoglu S, Cangul I, et al. The effects of a low dose of cabergoline on induction of estrus and pregnancy rates in anestrous bitches. Anim Reprod Sci. 2007;101:134–144
  3. Verstegen JP, Onclin K, Siva L, et al. Effect of stage of anestrus on the induction of estrus by the dopamine agonist cabergoline in dogs. Theriogenology. 1999;51(3):597–611
  4. Concannon PW, Temple M, Montanez A, et al: Effects of dose and duration of continuous GNRH-agonist treatment on induction of estrus in beagle dogs. Competing and concurrent upregulation and down-regulation of LH release. 66:1488-1496, 2006
  5. Barta M, Archbald LF, Godke RA. Luteal function of induced corpora lutea in the bitch. Theriogenology. 1982;18:541–549
  6. Kutzler MA. Induction and synchronization of estrus in dogs. Theriogenology. 2005;64(3):766–775
  7. Eilts BE. Pregnancy termination in the bitch and queen. Top Companion Anim Med. 2002;17:116–123
  8. Verstegen J. Contraception and pregnancy termination. In:  Ettinger SJ,  Feldman EC editor. Textbook of Veterinary Internal Medicine. (ed 2). Philadelphia: Saunders; 2000;p. 1542–1548
  9. Feldman EC, Davidson AP, Nelson RW, et al. Prostaglandin induction of abortion in pregnant bitches after misalliance. J Am Vet Med Assoc. 1993;202:1855–1858
  10. Feldman EC, Nelson RW. Induced abortion, pregnancy prevention and termination, and mismating. In:  Feldman EC,  Nelson RW editor. Canine and Feline Endocrinology and Reproduction. (ed 2). Philadelphia: W.B. Saunders; 1996;p. 592–605
  11. Oncline K, Silva L, Donnay I, et al. Luteotrophic action of prolactin in dogs and the effects of a dopamine agonist, cabergoline. J Reprod Fertil. 1993;47(Suppl):403–409
  12. Oncline K, Verstegen JP. Practical use of a combination of a dopamine antagonist and a synthetic prostaglandin analogue to terminate unwanted pregnancy in dogs. J Small Anim Prac. 1995;37:211–216
  13. Wanke M, Loza M, Monachesi N, et al. Clinical use of dexamethasone for termination of unwanted pregnancy in dogs. J Reprod Fert. 1997;51(Suppl):233–238
  14. Verstegen JP, Onclin K, Silva L, et al. Abortion induction in the cat using prostaglandin F2 alpha and a new anti-prolactinic agent, cabergoline. J Reprod Fert. 1993;47(Suppl):411–417
  15. Onclin K, Verstegen J. Termination of pregnancy in cats using a combination of cabergoline, a new dopamine agonist and a synthetic PGF (2-alpha), cloprostenol. J Reprod Fertil. 1997;51(Suppl):259–263
  16. Linde-Forsberg C, Kindahl H, Madej A. Termination of mid-term pregnancy in the dog with oral RU 486. J Small Animal Pract. 1992;33:331–336
  17. Galac S, Kooistra HS, Butinar J, et al. Termination of mid-gestation pregnancy in bitches with aglepristone, a progesterone receptor antagonist. Theriogenology. 2000;53:941–950
  18. Davidson A, Nyland TG, Toshihiko T. Pregnancy diagnosis with ultrasound in the domestic cat. Vet Radiol Ultrasound. 1986;27:109–114
  19. Shille VM, Thatcher MJ, Simmons KJ. Efforts to induce estrus in the bitch, using pituitary gonadotropins. J Am Vet Med Assoc. 1984;184:1469–1473
  20. Jeffcoate IA. Endocrinology of anestrous bitches. J Reprod Fertil. 1993;47:69–76
  21. Bouchard GF, Gross VK, Ganjam RS, et al. Oestrus induction in the bitch with the synthetic oestrogen diethylstilboestrol. J Reprod Fert. 1993;47:515–516
  22. Shielle VM, Thatcher MJ, Lloyd ML, et al. Gondotropin control of follicular development and the use of exogenous gonadotropins for induction of oestrus and ovulation in the bitch. J Reprod Fertil. 1989;39:103–113
  23. Concannon P, Lasley B, Vanderlip S. LH release, induction of oestrus and fertile ovulations in response to pulsate administration of GnRH to anoestrous dogs. J Reprod Fertil. 1997;51:1–54
  24. Arnold S, Arnold P, Concannon PW, et al. Effects of duration of PMSG treatment on induction of estrus, pregnancy rates, and the complications of hyperestrogenism in dogs. J Reprod Fertil. 1989;39:115–122
  25. Van Haaften B, Dieleman SJ, Okkens AC, et al. Induction of estrus and ovulation in dogs by treatment with PMSG and/or bromocriptine. J Reprod Fertil. 1989;39:330–331
  26. Verstegen J, Onclin K, Silva L, et al. Termination of obligate anestrus and induction of fertile ovarian cycles by administration of purified pig. J Reprod Fertil. 1997;111:35–40
  27. Jones GE, Boyns ET, Bell DW, et al. Immunoreactive luteinizing hormone and progesterone during pregnancy and following gonadotropin administration in beagle bitches. Acta Endocrinol. 1973;72:573–581
  28. Nakao T, Yukiyo A, Fukshima M, et al. Induction of estrus in bitches with exogenous gonadotropins and pregnancy rate and blood progesterone profiles. Jpn J Vet Sci. 1985;47:17–24
  29. Weilenmann R, Arnold S, Dobeli M, et al. Estrus induction in bitches by the administration of PMSG and HCG. Schweiz Arch Tierhelikd. 1993;135:236–241
  30. Arbeiter K, Brass W, Ballabio R, et al. Estrus induction and fertility with cabergoline, a prolactin inhibitor, in the bitch. J Small Anim Pract. 1988;29:781–788
  31. Jochle W, Arbeiter K, Post R, et al. Effects on pseudopregnancy, pregnancy and interoestrous intervals of pharmacological suppression of prolactin secretion in female dogs and cats. J Reprod Fertil. 1989;39:199–207
  32. Zoldag L, Fekete S, Csaky I, et al. Fertile estrus induced in bitches by bromocryptine a dopamine agonist; a clinical trail. Theriogenology. 2001;55:1657–1666
  33. Kutzler MA, Wheeler R, Lamb S, et al. Deslorelin implant administration beneath the vulvar mucosa for the induction of synchronous estrus in bitches [abstract]. In: Proceedings of the Annual Meeting of the European Veterinary Society of Small Animal Reproduction, Liege. 2002;
  34. McLean S, Brandon S, Kirkwood R. Stability of cabergoline in fox baits in laboratory and field conditions. Wildl Res. 2007;34:239–246
  35. Cain JL, Cain GR, Feldman EC, et al. Use of pulsatile intravenous administration of gonadotropin-release hormone to induce fertile estrus in bitches. Am J Vet Res. 1988;49:1993–1996
  36. Vanderlip SL, Wing AE, Felt P, et al. Ovulation induction in anestrous bitches by pulsatile administration of GnRH. Lab Anim Sci. 1987;27:459–468
  37. Hatoya S, Torii V, Wijewardana D, et al. Induction of fertile oestrus in bitches by an intranasal spray of gonadotrophin-releasing hormone agonist. Vet Rec. 2006;158:378–379
  38. Concannon PW. Induction of fertile oestrus in anoestrus dogs by constant infusion of GnRH agonist. J Reprod Fertil. 1989;39:149–160
  39. Kutzler MA, Wheeler R, Volkmann DH. Serum deslorelin concentrations in bitches after Ovuplant administration. In: Proceedings of the Annual Meeting of the Society of Theriogenology 13. 2001;
  40. Kutzler MA. Estrus induction and synchronization in canids and felids. Theriogenology. 2007;68(3):354–374
  41. Romagnoli S. Clinical approach to infertility in the queen. J Feline Med Surg. 2003;5:143–146
  42. Wildt DE, Guthrie SC, Seager SWJ. Ovarian and behavioral cyclicity of the laboratory maintained cat. Horm Behav. 1978;10:251–257
  43. Swanson WF, Graham K, Horohov DW, et al. Ancillary follicle and secondary corpora lutea formation following exogenous gonadotropin treatment in the domestic cat and effect of passive transfer of gonadotropin-neutralizing antisera. Theriogenology. 1996;45:561–572
  44. Concannon P. Estrus suppression in the bitch. In:  Bonagura JD,  Twedt DC editor. Kirk's Current Veterinary Therapy XIV. Philadelphia: Saunders; 2008;p. 1024–1030
  45. Baldwin CJ, Peter AT, Bosu WT, et al. The contraceptive effects of levonorgestrel in the domestic cat. Lab Anim Sci. 1994;44(3):261–264
  46. Walker J, Ghosh S, Pagnon J, et al. Totally synthetic peptide-based immunocontraceptive vaccines show activity in dogs of different breeds. Vaccine. 2007;25(41):7111–7119
  47. Inaba T, Tani H, Gonda M, et al. Induction of fertile estrus in bitches using a sustained-release formulation of a GnRH agonist (leuprolide acetate). Theriogenology. 1998;49(5):975–982
  48. Eilts BE. Canine pregnancy termination. In:  Bonagura JD,  Twedt DC editor. Kirk's Current Veterinary Therapy XIV. Philadelphia: Saunders; 2008;p. 1031–1033
  49. Bowen RA, Olson PN, Behrendt MD, et al. Efficacy and toxicity of estrogens commonly used to terminate canine pregnancy. J Am Vet Med Assoc. 1985;186:783–788
  50. Bowen RA, Olson PN, Young S, et al. Efficacy and toxicity of tamoxifen citrate for prevention and termination of pregnancy in bitches. Am J Vet Res. 1988;49:27–31
  51. Davidson AP, Nelson RW, Feldman EC. Induction of abortion in 9 bitches with intravaginal misoprostol and parenteral PGF 2-alpha [abstract]. J Vet Med. 1997;11:123
  52. Arbeiter K, Flatscher C. Induction of abortion in the bitch using cabergoline (Galastop). Kleintierprax. 1996;41:747
  53. Persiani S, Sassolas G, Piscitelli G, et al. Pharmacodynamics and relative bioavailability of cabergoline tablets versus solution in healthy volunteers. J Pharmacol Sci. 2006;83:1421–1424
  54. Fieni F, Tainturier D, Bruyas JF, et al. Etude clinique d'une anti-hormone pour provoquer I'avortement chez la chienne: l'aglepristone. Rec Med Vet. 1996;172:359–367
  55. Fieni F, Bruyas JF, Battut I, et al. Clinical use of anti-progestins in the bitch. In:  Concannon PW,  England G,  Verstegen J editor. Recent Advances in Small Animal Reproduction. Ithaca, New York: International Veterinary Information Service; 2001;p. A1219.0201
  56. Keister DM, Gutheil RF, Kaiser LD, et al. Efficacy of oral epostane administration to terminate pregnancy in mated laboratory bitches. J Reprod Fertil. 1989;39(Suppl):241–249
  57. Biddle D, Macintire DK. Obstetrical emergencies. Clin Tech Small Anim Pract. 2000;15(2):88–93
  58. Egenvall A, Hagman R, Bonnett BN, et al. Breed risk of pyometra in insured dogs in Sweden. J Vet Intern Med. 2001;15:530–538
  59. Hardy RM, Osborne CA. Canine pyometra: pathophysiology, diagnosis, and treatment of uterine and extrauterine lesions. J Am Anim Hosp Assoc. 1974;10:245–268
  60. Lee S, Cho J, Shin N, et al. Identification and antimicrobial susceptibility of bacteria from the uterus of bitches with pyometra. Korean J Vet Res. 2000;40:763–767
  61. Fransson BA, Ragle CA. Canine pyometra: an update on pathogenesis and treatment. Compend Cont Educ Pract Vet. 2003;25:602–612
  62. Barsanti JA. Genitourinary infections. In:  Greene CE editors. Infectious Diseases of the Dog and Cat. St Louis: Elsevier; 2006;p. 958–959
  63. Brown SA. Fluoroquinolones in animal health. J Vet Pharmacol Ther. 1996;19:1–14
  64. Sridevi P, Balasubramanian S, Devanathan TG, et al. Low dose prostaglandin F2 alpha therapy in treatment of canine pyometra. Indian Vet J. 2000;77:889–890
  65. Gabor G, Siver L, Szenci O. Intravaginal prostaglandin F2alpha for the treatment of metritis and pyometra in the bitch. Acta Vet Hung. 1999;47:103–108
  66. Hecker BR, Wehrend A, Bostedt H. Konservative behandlung der pyometra bei der katze mit dem antigestagen Aglépristone. Kleintierpraxis. 2000;45:845–848
  67. Heiene R, Moe L. The relationship between some plasma clearance methods for estimation of glomerular filtration rate in dogs with pyometra. J Vet Intern Med. 1999;13:587–596
  68. Hoffman B, Lemmer W, Bostedt H, et al. Die anwendug des antigestagens Aglépristone zur konservativen behandlung der pyometra bei der hündin. Tierärztl Prax. 2000;28:323–329
  69. Heiene R, Kristiansen V, Teig J, et al. Renal histomorphology in dogs with pyometra and control dogs, and long term clinical outcome with respect to signs of kidney disease. Acta Vet Scand. 2007;49:13
  70. Linde-Forsberg C, Eneroth A. Abnormalities in pregnancy, parturition and the periparturient period. In: Ettinger ,  Feldman SJ editor. EC Textbook of Veterinary Internal Medicine. Philadelphia: WB Saunders; 2000;p. 1527–1538
  71. Gunn-Moore DA, Thrusfield MV. Feline dystocia: prevalence and association with cranial conformation and breed. Vet Rec. 1995;136:350–353
  72. Shull RM, Johnston SD, Johnston GR, et al. Bilateral torsion of uterine horns in a non-gravid bitch. J Am Vet Med Assoc. 1978;172:601–603
  73. Pretzer SD. Medical management of canine and feline dystocia. Theriology. 2008;70:332–336
  74. Davidson AP. Uterine and fetal monitoring in the bitch. Vet Clin North Am Small Anim Pract. 2001;31:305–313
  75. Johnston SD, Kustritz MVR, Olson PNS. Disorders of the canine uterus and uterine tubes (oviducts). In:  Kersey R editors. Canine and Feline Theriogenology. Philadelphia: WB Saunders; 2001;p. 206–224
  76. Van Der Weijden GC, Taverne MAM. Aspects of obstetric care in the dog. Vet Q. 1994;16:20–22
  77. Bergstrom A, Fransson B, Lagerstedt AS, et al. Primary uterine inertia in 27 bitches: aetiology and treatment. J Small Anim Pract. 2006;47:456–460
  78. Olsson K, Bergstrom H, Kindahi H, et al. Increased plasma concentrations of vasopressin, oxytocin, cortisol, and the prostaglandin F2 alpha metabolite during labour in the dog. Acta Physiol Scand. 2003;179:1–7
  79. Feldman EC, Nelson RW. Feline reproduction. In:  Kersey R editors. Canine and Feline Endocrinology and Reproduction. Philadelphia: WB Saunders; 2004;p. 1016–1045
  80. Drobatz KJ, Casey KK. Eclampsia in dogs; 31 cases: 1995-1998. J Am Vet Med Assoc. 2000;217:216
  81. Kutzeler MA. Canine postpartum disorders. In:  Bonagura JD,  Twedt DC editor. Kirk's Current Veterinary Therapy XIV. Philadelphia: Saunders; 2008;p. 999–1002
  82. Freshman JL. Pregnancy loss in the bitch. In:  Bonagura JD,  Twedt DC editor. Kirk's Current Veterinary Therapy XIV. Philadelphia: Saunders; 2008;p. 986–989
  83. Papatsonis D, Flenady V, Cole S, et al. Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database Syst Rev. 2005;20(3):CD004452
  84. Laohapojanart N, Soorapan S, Wacharaprechanont T, et al. Safety and efficacy of oral nifedipine versus terbutaline injection in preterm labor. J Med Assoc Thai. 2007;90:2461–2469
  85. Norton ME, Merrill J, Cooper B, et al. Neonatal complications after the administration of indomethacin for preterm labor. New Engl J Med. 1993;329:1602–1607
  86. Sher G, Fisch JD. Vaginal sildenafil (Viagra): a preliminary report of a novel method to improve uterine artery blood flow and endometrial development in patients undergoing IVF. Hum Reprod. 2000;15(4):806–809
  87. Villanueva-Garcia D, Mota-Rojas D, Hernandez-Gonzalez R, et al. A systematic review of experimental and clinical studies of sildenafil citrate for intrauterine growth restriction and pre-term labour. J Obstet Gynaecol. 2007;27:255–259
  88. Webster WS, Freeman SA. Prescription drugs and pregnancy. Expert Opin Pharmacother. 2003;4(6):949–961
  89. Berglund F, Flodh H, Lundberg P: Drug use during pregnancy and breast-feeding. A classification system for drug information. 126:1-55, 1984 (Suppl)
  90. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. In: A Reference Guide to Fetal and Neonatal Risk. (ed 6). Philadelphia: Lippincott Williams and Wilkins; 2002;
  91. Flores-Castro R, Suarez F, Ramirez-Pfeiffer C, et al. Canine brucellosis: bacteriological and serological investigation of naturally infected dogs in Mexico City. J Clin Microbiol. 1977;591–597(Dec)
  92. Johnson CA, Walker RD. Clinical signs and diagnosis of Brucella canis. Infect Comp Cont Ed. 1992;14:763–772
  93. Nicoletti P. Further studies on the use of antibiotics in canine brucellosis. Comp Cont Ed. 1991;13:944–946
  94. Wanke MM, Delpino MV, Baldi PC. Use of enrofloxacin in the treatment of canine brucellosis in a dog kennel (clinical trial). Theriogenology. 2006;66(6-7):1573–1578
  95. Wallach JC, Giambartolomei GH, Baldi PC, et al. Human infection with M-strain of Brucella canis. Emerg Infect Dis. 2004;10:1–6
  96. Solera J, Martinez-Alfaro E, Saez L. [Meta-analysis of the efficacy of the combination of +rifampicin and doxycycline in the treatment of human brucellosis]. Med Clin (Barc). 1994;102:731–738
  97. Vinayak A, Greene CE, Moore PA, et al. Clinical resolution of Brucella canis–induced ocular inflammation in a dog. J Am Vet Med Assoc. 2004;224(11):1804–1807
  98. Skalsky K, Yahav D, Bishara J, et al. Treatment of human brucellosis: systemic review and meta-analysis of randomized controlled trials. BMJ. 2008;336(7646):701–704
  99. Salata RA. Brucellosis. In:  Goldman L editors. Cecil Textbook of Medicine. (ed 22). Philadelphia: WB Saunders; 2004;p. 1887–1890
  100. Moudgal VV, Sobel JD. Antifungal drugs in pregnancy: a review. Expert Opin Drug Saf. 2003;2(5):475–483
  101. Pagliano P, Attanasio V, Fusco U, et al. Pulmonary aspergillosis with possible cerebral involvement in a previously healthy pregnant woman. J Chemother. 2004;16(6):604–607
  102. Garcia-Heredia M, Garcia SD, Copolillo EF, et al: Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents. 38(1):9-12, 2006
  103. Crum NF, Ballon-Landa G. Coccidiodomycosis in pregnancy: case report and review of the literature. Am J Med. 2006;119(11):993
  104. Tiboni GM, Marotta F, Del Corso A, et al. Defining critical periods for itraconazole-induced cleft palate, limb defects and axial skeletal malformations in the mouse. Toxicol Lett. 2006;167(1):8–18
  105. Tiboni GM, Giampietro F. Murine teratology of fluconazole: evaluation of developmental phase specificity and dose dependence. Pediatr Res. 2005;58(1):94–99
  106. Bar-Oz B, Moretti ME, Bishai R, et al. Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study. Am J Obstet Gynecol. 2000;183(3):617–620
  107. Mastroiacovo P, Mazzone T, Botto L, et al. Prospective assessment of pregnancy outcomes after first-trimester exposure to fluconazole. Am J Obstet Gynecol. 1996;175:1645–1650
  108. Menegola E, Broccia ML, Di Renzo F, et al. Study on the common teratogenic pathway elicited by the fungicides triazole-derivatives. Toxicol In Vitro. 2005;19(6):737–748
  109. Guillot J, Malandain E, Jankowski F, et al. Evaluation of the efficacy of oral lufenuron combined with topical enilconazole for the management of dermatophytosis in catteries. Vet Rec. 2002;150(23):714–718
  110. Moriello KA, Deboer DJ, Schenker R, et al. Efficacy of pre-treatment with lufenuron for the prevention of Microsporum canis infection in a feline direct topical challenge model. Vet Dermatol. 2004;15(6):357–362
  111. Scott FW, LaHunta A, Schultz RD, et al. Teratogenesis in cats associated with griseofulvin therapy. Teratology. 1975;11(1):79–86
  112. Foley J, Bannasch M. Infectious diseases of dogs and cats. In:  Miller L,  Zawistowski S editor. Shelter Medicine for Veterinarians and Staff. (ed 1). Ames, Iowa: Blackwell Publishing; 2004;p. 235–284
  113. Newbury S, Moriello K, Verbrugge M, et al. Use of lime sulphur and itraconazole to treat shelter cats naturally infected with Microsporum canis in an annex facility: an open field trial. Vet Dermatol. 2007;18(5):324–331
  114. Proakis AG, Harris GB. Comparative penetration of glycopyrrolate and atropine across the blood brain and placental barriers in anesthetized dogs. Anesthesiology. 1978;48:339–344
  115. Paddleford RR. In: Manual of Small Animal Anesthesia (Chapter 12. Patients with preexisting problems or conditions). (ed 2). Philadelphia: WB Saunders; 1999;p. 300–317
  116. Seymour C. Caesarian section. In:  Duke-Novakovski T editors. British Small Animal Veterinary Association, Manual of Canine and Feline Anesthesia and Analgesia. (ed 2). 2007;p. 217–222Shurdington, Cheltenham, UK. Chapter 18
  117. Hall LW, Clarke KW, Trim CM. Anesthesia for Obstetrics: Veterinary Anesthesia. In: (ed 10). Philadelphia: Saunders Elsevier Limited; 2001;p. 488–491Chapter 18
  118. Goodger WJ, Levy W. Anesthetic management of the cesarean section. Vet Clin North Am. 1973;3:85–99
  119. Gutsche B. Perinatal pharmacology. In: Annual Refresher Course Lectures. Park Ridge, IL: American Society of Anesthesiologists; 1978;p. 1291–1299
  120. Gibbs CP. Anesthesia for cesarean section: general. In: Annual Refresher Course Lectures. Park Ridge, IL: American Society of Anesthesiologists; 1981;p. 2181–2185
  121. Datta S, Alper MH. Anesthesia for cesarean section. Anesthesiology. 1980;53:142–160
  122. Funkquist PM, Nyman GC, Lofgren AJ, et al. Use of propofol-isoflurane as an anesthetic regimen for cesarean section in dogs. J Am Vet Med Assoc. 1997;211:313–317
  123. Moon PF, Erb HN, Ludders JW, et al. Perioperative risk factors for puppies delivered by cesarean section in the United States and Canada. J Am Anim Hosp Assoc. 2000;36:359–368
  124. Moon-Massat PF, Erb HN. Perioperative factors associated with puppy vigor after delivery by cesarean section. J Am Anim Hosp Assoc. 2002;38:90–96
  125. Biehl DR, Yarnell R. The uptake of isoflurane by the foetal lamb in utero; effect on regional blood flow. Can Anaesth Soc. 1983;30:581–586
  126. Krammer F, Hammerstein R, Stoye M, et al. Investigations into the prevention of prenatal and lactogenic Toxocara canis infections in puppies by application of moxidectin to the pregnant dog. J Vet Med. 2006;53:218–223
  127. Epe C, Roesler K, Schnieder T, et al. Investigations into the prevention of neonatal Ancylostoma caninum infections in puppies by application of moxidectin to the bitch. Zentralbl Veterinarmed B. 1999;46(6):361–367
  128. Ridley RK, Dryden MW, Gabbert NH, et al. Epidemiology and control of helminth parasites in greyhound breeding farms. Comp Contin Edu Pract. 1994;16:585–599
  129. Burke TM, Roberson EL. Prenatal and lactational transmission of Toxocara canis and Ancylostoma caninum: experimental infection of the bitch before pregnancy. Int J Parasitol. 1985;15:71–75
  130. Lloyd S, Soulsby EJL. Prenatal and transmammary infections of Toxocara canis in dogs: effects of bencimidazole carbamate anthelminthics on various developmental stages of the parasite. J Small Anim Pract. 1983;24:763–768
  131. Okoshi S, Usal M: Experimental studies on Toxascaris leonine VI. Experimental infection of mice, chickens and earthworms with Toxascaris leonine, Toxocara canis and Toxocara cati 30:151-160, 1968
  132. Mantovani A, Macri C, Stazi AV, et al. Effects of albendazole on the early phases of rat organogenesis in vivo: preliminary results [abstract]. Teratology. 1992;46:25A
  133. Burke TM, Roberson EL. Fenbendazole treatment of pregnant bitches to reduce prenatal and lactogenic infections of Toxocara canis and Ancylsotoma caninum in pups. J Am Vet Med Assoc. 1983;183:987–990
  134. Bosse M, Manhardt J, Stoye M. Epizootiologie and Bekempfung neonataler helmintheninfektionen des hundes. Fortschr Vet Med. 1980;30:247–256
  135. Bosse M, Stoye M. Zurwirkung ver schiedener benzimidazolcarbamate auf somatische Larven von Ancyclostoma canium Ercolani 1859 (Ancyclostomidae) und Toxocara canis Werner 1792 (Anisakidae). Zentralbl Bakteriol. 1981;28:265–279
  136. Fletouris DJ, Botsoglou NA, Psomas IE, et al. Trace analysis of albendazole and its sulphoxide and sulphone metabolites in milk by liquid chromatography B. Biomed Appl. 1996;687:427–435
  137. American Hospital Formulary Service. Drug Information. In: Bethesda, Maryland: American Society of Health-System Pharmacists; 1997;p. 44–46
  138. Owaki Y, Sakai T, Momiyama H. Teratological studies on pyrantel pamoate in rabbits. Oyo Yakuri. 1971;5:33–39
  139. Jacobs DE. Control of Toxocara canis in puppies: a comparison of screening techniques and evaluation of a dosing programme. J Vet Pharmacol Ther. 1987;10(1):23–29
  140. Epe C, Pankow WR, Mackbarth H, et al. A study on the prevention of prenatal and galactogenic Toxocara canis infections in pups by treatment of infected bitches with ivermectin or dormectin. Appl Parasitol. 1995;36:115–123
  141. Schnieder TS, Kordes C, Epe S, et al. Investigations into the prevention of neonatal Toxocara canis infections in puppies by application of dormectin to the bitch. J Vet Med. 1996;43:35–43
  142. Payne PA, Ridley RK. Strategic use of ivermectin during pregnancy to control Toxocara canis in greyhound puppies. Vet Parasitol. 1999;85:305–312
  143. Pacque M, Munoz B, Poetschke G, et al. Pregnancy outcome after inadvertent ivermectin treatment during community-based distribution. Lancet. 1990;336:1486–1489
  144. In:  Campbell WC editors. Ivermectin and Abamectin. New York: Springer-Verlag; 1989;
  145. Stromectol package insert (Merck US). Issued November 1996, recorded June 1998.
  146. Payne-Johnson M, Maitland TP, Sherington J, et al. Efficacy of selamectin administrated topically to pregnant and lactating female dogs in the treatment and prevention of adult roundworm (Toxocara canis) infections and flea (Ctenocephalides felis) infestations in the dams and their pups. Vet Parasitol. 2000;91(3-4):347–358
  147. Heine J, Krieger K, Dumont P, et al. Evaluation of the efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of generalized demodicosis in dogs: results of a European field study. Parasitol Res. 2005;97(Suppl 1):81–88
  148. Fulton RW, Oh RL, Duenwaid JC, et al. Serum antibodies against canine respiratory viruses: prevalence among dogs of Eastern Washington. Am J Vet Res. 1974;35:853–855
  149. Anvik JO. Clinical considerations of canine herpes virus infection. Vet Med. 1991;86:394–403
  150. Davidson AP, Grundy SA, Foley JE. Successful medical management of neonatal canine herpes virus; a case report. Theriogenology. 2003;3(1):115–120
  151. Poulet PM, Guigal PM, Soulier M. Protection of puppies against canine herpesvirus by vaccination of the dams. Vet Rec. 2001;148:691–695
  152. Greene CE, Schultz RD. Immunoprophylaxis. In:  Greene CE editors. Infectious Diseases of the Dog and Cat. Philadelphia: WB Saunders; 2006;p. 369–381
  153. Sager M, Remmers C: Perinatal mortality in dogs. Clinical, bacteriological and pathological studies. 18(4):415-419, 1990
  154. Stafford I, Hernandez J, Laibl V, et al. Community acquired methicillin-resistant Staphylococcus aureus among patients with puerperal mastitis requiring hospitalization. Obstet Gynecol. 2008;112(3):533–537
  155. Wang JL, Chen SY, Wang JT, et al. Comparison of clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin susceptible S. aureus. Clin Infect Dis. 2008;46(6):799–806
  156. Hasegawa T, Fuggi M, Fukada T, et al. Platelet abnormalities in a dog suffering from gangrenous mastitis by Staphylococcus aureus infection. J Vet Med Sci. 1993;55(1):169–171
  157. Ververidis HN, Mavrogianni VS, Fragkou IA, et al. Experimental staphylococcal mastitis in bitches: clinical, bacteriological, cytological, haematological and pathological features. Vet Microbiol. 2007;124:95–106
  158. Schafer-Somi S, Spergser J, Breitenfellner J, et al. Bacterial status of canine milk and septicaemia in neonatal puppies—a retrospective study. J Vet Med. 2003;50(7):343–346
  159. Baba E, Hata H, Fukata T, et al. Vaginal and uterine microflora of adult dogs. Am J Vet Res. 1983;44:606–609
  160. Rekha BS, Krishnappa G. Bacterial flora in canine pyometra. Indian Vet J. 2001;78:773–774
  161. Memon MA. Common causes of male infertility. Theriogenology. 2007;68(3):322–328
  162. Romagnoli S. Two common causes of infertility in the male dog. In: Proceedings of the World Small Animal Veterinary Association. 2006;p. 687–690
  163. Kustritz MV, Hess M. Effect of administration of prostaglandin F2 alpha or presence of an estrous teaser bitch on characteristics of the canine ejaculate. Theriology. 2007;67(2):255–258
  164. Johnson SD, Kustritz MVR, Olson PNS. Disorders of the canine testes and epididymes. In:  Kersey R editors. Canine and Feline Theriogenology. Philadelphia: WB Saunders; 2001;p. 312–332
  165. Sirinarumitr K, Johnson SD, Kustritz GR, et al. Effects of finasteride on size of the prostate gland and semen quality in dogs with benign prostatic hypertrophy. J Am Vet Med Assoc. 2001;218:1275–1280
  166. Rhodes L. The role of dihydrotestosterone in prostate physiology; comparison among rats, dogs and primates. In: Proceedings of the Annual Meeting of the Society of Theriogenology. 1996;p. 124–135
  167. Wallace M. Diagnosis and medical management of canine prostatic disease. In: Proceedings of the Atlantic Coast Veterinary Conference. 2001;
  168. Gradil CM, Yeager A, Concannon PW. Assessment of reproductive problems in the male dog. In:  Concannon PW,  England G,  Verstegen J,  Linde-Forsberg C editor. Recent Advances in Small Animal Reproduction. Ithaca, New York: International Veterinary Information Service; 2006;(www.ivis.org) Last update 19-Apr-2006; A1234.0406

PII: S1938-9736(09)00004-X

doi: 10.1053/j.tcam.2008.12.004

Topics in Companion Animal Medicine
Volume 24, Issue 2 , Pages 71-99 , May 2009

Article Tools